Creo Medical Group PLC
LSE:CREO
EV/IC
Enterprise Value to IC
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
Market Cap | EV/IC | ||||
---|---|---|---|---|---|
UK |
Creo Medical Group PLC
LSE:CREO
|
129.1m GBP | 2 | ||
US |
Abbott Laboratories
NYSE:ABT
|
179.5B USD | 3 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.9B USD | 12.8 | ||
US |
Stryker Corp
NYSE:SYK
|
125.6B USD | 3.7 | ||
IE |
Medtronic PLC
NYSE:MDT
|
112.4B USD | 1.6 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
110.8B USD | 3.5 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.9B USD | 1.8 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
59B EUR | 1.7 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
54B USD | 7.6 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
51.8B USD | 15.5 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
369.6B CNY | 13.2 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.